Women with polycystic ovary syndrome are burdened with multimorbidity and medication use independent of body mass index at late fertile age: A population‐based cohort study

• DOI: 10.1111/aogs.14382
• Publication Date: 2022-06-08T08:02:31Z
• Authors: Linda Kujanpää; Riikka K. Arffman; Paula Pesonen; Elisa Korhonen; Salla Karjula; Marjo‐Riitta Järv...; Stephen Franks; Juha S. Tapanainen; Laure Morin‐Papunen; Terhi T. Piltonen
• Keywords: Adult; SYMPTOMS; multimorbidity; Epidemiology; medication use; 1117 Public Health and Health Services; Body Mass Index; Cohort Studies; 03 medical and health sciences; 0302 clinical medicine; cohort study; PCOS; ANXIETY; Humans; Obstetrics & Reproductive Medicine; Gynaecology and paediatrics; 2. Zero hunger; Science & Technology; Obstetrics & Gynecology; Multimorbidity; Middle Aged; DEPRESSION; PREVALENCE; 3. Good health; LIFE; comorbidity; polycystic ovary syndrome; 1114 Paediatrics and Reproductive Medicine; Female; HEALTH; FOLLOW-UP; Life Sciences & Biomedicine; Follow-Up Studies; Polycystic Ovary Syndrome

This population-based follow-up study investigated the comorbidities, medication use, and healthcare services among women with polycystic ovary syndrome (PCOS) at age 46 years.